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ORIGINAL ARTICLEMucus Microbiome of Anastomotic Tissue During Surgery
orectal Anastomotic LeakageHas Predictive Value for ColJasper B. van Praagh, BSc, Marcus C. de Goffau, PhD,yz Ilsalien S. Bakker, MD, PhD,§
Harry van Goor, PhD,jj Hermie J. M. Harmsen, PhD,y Peter Olinga, PhD, and Klaas Havenga, MD, PhDObjective: The aim of the present study is to investigate the association of gut
microbiota, depending on treatment method, with the development of colo-
rectal anastomotic leakage (AL).
Background: AL is a major cause for morbidity and mortality after colorec-
tal surgery, but the mechanism behind this complication still is not fully
understood.
Methods: Bacterial DNAwas isolated from 123 ‘‘donuts’’ of patients where a
stapled colorectal anastomosis was made and was analyzed using 16S MiSeq
sequencing. In 63 patients, this anastomosis was covered with a C-seal, a
bioresorbable sheath stapled to the anastomosis.
Results: In non-C-seal patients, AL development was associated with low
microbial diversity (P¼ 0.002) and correspondingly with a high abundance of
the dominant Bacteroidaceae and Lachnospiraceae families (P ¼ 0.008 and
0.010, respectively). In C-seal samples, where AL rates were slightly higher
(25% vs 17%), an association with the gut microbiota composition was almost
undetectable. Only a few opportunistic pathogenic groups of low abundance
were associated with AL in C-seal patients, in particular Prevotella oralis
(P ¼ 0.007).
Conclusions: AL in patients without a C-seal can be linked to the intestinal
microbiota, in particular with a low microbial diversity and a higher abun-
dance of especially mucin-degrading members of the Bacteroidaceae and
Lachnospiraceae families. In C-seal patients, however, it seems that any
potential protective benefits or harmful consequences of the gut microbiota
composition in regard to wound healing are negated, as progression to AL is
independent of the initially dominant bacterial composition.
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surgery
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Annals of Surgery  Volume 269, Number 5, May 2019A nastomotic leakage (AL) remains the main cause for morbidityandmortality in colorectal resection surgery, leading to prolonged
hospital stays and significant costs.1–3 Although surgical factors as
perfusion of and tension on the anastomosis and patient-related factors
as comorbidity and medication are known factors, in many cases no
explanation can be given for the failure of anastomotic healing.
It is well recognized that the gut microbiota plays an important
role in human health, and an expanding list of diseases has been
associated with the microbial composition and/or their products.4
Intestinal diseases, in particular, have been associated with the intesti-
nal microbiota.4–6 Products produced by bacteria, such as short-chain
fatty acids (SCFAs), are important for colonic cells. Butyrate, for
example, is the primary energy source for colonic cells.7 In addition to
its importance in the defense against opportunistic pathogens, the
glycoproteins in the mucus layer (mucin) also serve as a source of
nutrients for commensals/symbionts such as the anti-inflammatory
butyrate-producing bacterium Faecalibacterium prausnitzii.8 How-
ever, when the supply of butyrate to the colon is diminished or stopped,
the colonic mucosa may enter a state of energy deprivation, leading to
colitis and diarrhea.9,10 Furthermore, the colonic microbiota is also
important in regard to wound healing.11 In addition, selective decon-
tamination of the digestive tract reduces infections and seems to have a
beneficial effect on AL in colorectal surgery.12
In a previous pilot study,13 we investigated the possible role of
colonic microbiota in AL using samples from 8 patients who devel-
oped AL matched with 8 patients without AL who were included in
the C-seal trial14 but who were not treated with a C-seal. We found
that an overabundance of bacteria from Lachnospiraceae family and
low microbial diversity were linked to AL development.
The aim of the present exploratory study is to investigate the
role of the gut microbiota using 16S rRNA analysis, in the develop-
ment of AL in greater detail using a larger group of patients, and to
analyze whether the use of a C-seal during treatment, an intraluminal
sheet originally designed for the protection of the anastomosis,14
influences the role between the gut microbiota composition and
AL development.
METHODS
The methods used for this study are the same as described in
the previously performed pilot study.13
Patients
Twenty-nine patients who developed AL were matched on
sex, age, and preoperative chemotherapy and radiotherapy with 94
patients without AL. AL was defined as AL leading to a reinter-
vention. All patients participated in the C-seal trial, a trial to evaluate
the effect of the C-seal in the prevention of clinical AL in the stapled
colorectal anastomosis. This multicenter trial was designed to eval-
uate the efficacy of the C-seal; the primary endpoint was AL
requiring reintervention. This trial was open for inclusion from
December 2011 until January 2014.
The study was approved by the Medical Ethics Committee of
the University Medical Centre Groningen and all participating
www.annalsofsurgery.com | 911
regard to AL and non-AL samples.




(n ¼ 94) P
C-seal/no C-seal 18/11 45/49 0.207
Sex male/female 22/7 61/23 0.365
Age, y (SD) 63.4 (10.4) 63.4 (10.4) 0.510
Body mass index (SD), kg/m2 26.0 (3.9) 26.9 (4.0) 0.075
Charlson comorbidity index 0.415
0 16 56 0.830
1 5 23 0.462
2þ 8 15 0.179
Indication for surgery
Colorectal cancer 26 91




No radiotherapy 13 39 0.831
Short course 11 28 0.494
Long course 5 27 0.240
Chemotherapy 5 30 0.160
Corticosteroid use 1 3 0.999
Deviating ostomy present 1 9 0.449
ASA-score
1 7 19 0.795
2 17 64 0.376
3 5 11 0.528
All patients received mechanical oral bowel preparation and antibiotics prophylaxis.
van Praagh et al Annals of Surgery  Volume 269, Number 5, May 2019centers. The trial was registered in The Netherlands National Trial
Register under the number NTR3080. In total 539 patients were
included; all patients provided written informed consent; and addi-
tional consent was asked to retrieve and store the circular stapler
donuts. All data were collected anonymously, encoded, and saved in
a database.
Sample Collection
Bacterial DNA of the available proximal donuts was isolated
and subsequently analyzed using MiSeq sequencing of the amplified
16S rRNA genes. The reason for studying 16S rRNA genes using
MiSeq sequencing is because all bacteria have 16S rRNA genes, and
the small differences in their 16S rRNA genes allow us to identify all
the microbial groups present within a sample. Sequencing allows us
to quantitatively analyze the relative abundance of all species,
including species which we are yet unable to culture in the laboratory.
The often complex bacterial composition of a sample, including the
analysis of more rare low-abundant bacteria, can hence be measured
in a much more cost-effective and accurate fashion than was possible
with previous microbiome classification methods such as fluorescent
in situ hybridization microscopy counting techniques.
DNA Extraction and MiSeq Preparation
Total DNA was extracted, as described by de Goffau et al,15
from 0.25 g of a ‘‘donut.’’ Care was taken not to include any
macroscopic traces of stool. The additional purification steps using
columns were not needed after DNA precipitation. The V3 to V4
region of the 16S rRNA gene was amplified from the DNA by PCR
using modified 341F and 806R primers with a 6-nucleotide barcode




GGTWTCTAAT, respectively, where lowercase letters denote adapter
sequences necessary for binding to the flow cell, underlined lowercase
letters are binding sites for the Illumina sequencing primers, bold
uppercase letters highlight the index sequences as reported byBartram
et al,16 and regular uppercase letters are the V3 to V4 region primers
(341F for the forward primers and 806R for the reverse primers). The
inclusion of 4 maximally degenerated bases (NNNN) maximizes
diversity during the first 4 bases of the run. A detailed description
of the PCR, DNA cleanup, and MiSeq library preparation, as
described by Heida et al,17 are found in Supplementary Data file 1,
http://links.lww.com/SLA/B359.
MiSeq Sequencing Pipeline and Statistical Analysis
Software that was used to analyze the data received from
Illumina paired-end sequencing included PANDAseq,18 QIIME, and
ARB.19 Reads with a quality score <0.9 were discarded by PAN-
DAseq. Statistical analyses were performed on the family, genus, and
species level. QIIME identified sequences down to the family and
genus level and was used to perform weighted alpha-diversity
analyses, whereas ARB was used to identify sequences down to
the species level. Principal component analysis (PCA) was per-
formed to describe the variation in all the bacterial groups into a
very limited amount of new relevant dimensions of variability to
address the issue of multiple testing. The hierarchical clustering
analysis was performed with the Hierarchical Clustering Explorer
version 3.0 (http://www.cs.umd.edu/hcil/ multi-cluster/). Percen-
tages (%) given of a microbial group in a group of patients indicate
the average percentage of reads assigned to that group. The Simpson
index was used as a measure of microbial diversity. Nonparametric
tests were used, as microbial abundances are rarely normally distrib-
uted and are preferred as they are more conservative.Mann–Whitney
912 | www.annalsofsurgery.comU or Spearman’s r tests were used as indicated. The use  indicates
that a standard deviation is given. All tests were two-tailed, and a P<
0.05 was considered to indicate statistical significance. All statistical
analyses were performed using IBM SPSS Statistics 20.0.
RESULTS
Of 123 samples in total, 122 were included in the PCA, as 1
sample had an insufficient amount of bacterial DNA (Table 1).
However, 3 C-seal AL patients and 1 non-C-seal AL patient were
excluded from subsequent statistical analyses, as clear nonmicro-
biota-related reasons were found why these patients developed AL; 3
had necrosis of the proximal bowel loop and 1 had a technical failure
of the C-seal.
Surprisingly almost no difference was found between AL and
non-AL patients when the 118 samples were analyzed together; only
the Blautia genus was more abundant among AL patients (P ¼
0.040). However, when we looked at the subgroup of non-C-seal
patients, the microbiota of AL versus non-AL was different.
Sixty samples were from patients who were randomized to the
C-seal group and 58 were from the group without a C-seal. Of the 60
C-seal patients, 15 developed AL, whereas this number was 10 of the
58 in the non-C-seal patients. In a comparison of the C-seal samples
with all the non-C-seal samples, no statistically relevant differences
were found in bacterial compositions either on the genus or family
level. However, AL patients without a C-seal had a much lower
microbial diversity (P¼ 0.006), more Bacteroides (P¼ 0.006), more
Lachnospiraceae (P ¼ 0.05), and less Prevotella (P ¼ 0.05) and
Streptococci (P ¼ 0.03) than C-seal patients who developed AL. All
other patient characteristics were, in comparison with the presence or
absence of a C-seal, irrelevant. Striking differences were subse-
quently revealed between C-seal samples and non-C-seal samples in 2017 The Author(s). Published by Wolters Kluwer Health, Inc.
FIGURE 1. Principal component analysis
(PCA) plot of all 122 samples, divided over
all 4 groups and relevant associations.
PC1, represented by the x-axis, is associ-
ated with AL in non-C-seal patients and
describes 58%of the variation in the data.
PC3, represented by the y-axis, is posi-
tively associated with microbial diversity
and negatively associated with AL and
describes 6% of the variation in the data.
Vectors in theupper right corner represent
the correlation coefficients of the respec-
tive variables with PC1 and PC3. Colored
vectors correspond to the AL and C-seal
statusas indicated in the legend. Innon-C-
seal patients, the AL cases nearly without
exception found in the lower bottom cor-
ner, as indicated with a dashed red circle,
which is indicative of a microbiota domi-
nated by Lachnospiraceae and Bacteroida-
ceae of low diversity. Non-C-seal controls
aremore commonly found to have higher
scores on PC3, which is associated with a
higher microbial diversity, containing
more Ruminococcaceae, more Prevotella
copri, and/or more Streptococcaceae.
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Analysis
A PCA plot showed all 122 samples, divided into 4 main
groups based upon C-seal status and AL occurrence, combined with a
correlation analysis of the main microbial groups and microbial
diversity (Fig. 1). This highlights some of the main differences
between C-seal patients and non-C-seal patients with respect to
clinical outcome. The most striking aspect of Figure 1 is how nearly
all non-C-seal AL samples cluster together in the lower right corner
as indicated with a red dashed circle, whereas the other 3groups have
a seemingly identical distribution. Correlation analyses confirm that
the clustering/scattering of C-seal AL samples and C-seal non-AL
samples is almost identical, indicating that in the C-seal patients the
dominant microbial composition of the samples is unlikely to be
related to the development of AL. The distribution of non-C-seal
non-AL samples at first glance seems to be similar to the distribution
of C-seal patients, yet correlation analyses show that these samples
tend to be more located to the upper left. Non-C-seal AL samples
score higher on PC1 (P¼ 0.012) and lower on PC3 (P¼ 0.0006) than
non-C-seal non-AL samples. The localization of samples in the lower
right corner is associated with a bacterial composition that is strongly
dominated by Lachnospiraceae and/or Bacteroidaceae and that is
consequently low in microbial diversity.
A hierarchical clustering analysis on the C-seal samples in
combination with a microbial profile at the family level yet again
showed a homogenous distribution in both AL and non-AL samples
(data not shown). However, when this technique is applied to the non-
C-seal samples, a cluster of samples is found within the hierarchical
clustering in which AL samples are overrepresented (7/14 vs 3/44, P
¼ 0.0002) and in which Lachnospiraceae are dominant (40%)
followed by Bacteroidaceae (28%) (Supplemental Figure 1, http://
links.lww.com/SLA/B359). Furthermore, a microbial profile of non-
C-seal samples with a focus on both the microbial diversity, which is
lower in the AL samples (P ¼ 0.002), and the combined prevalence
of Lachnospiraceae and Bacteroidaceae underscores the strong
association of these family groups (Fig. 2) with the occurrence of AL.
 2017 The Author(s). Published by Wolters Kluwer Health, Inc.Taxonomic Analysis
Individual analyses of taxonomic groups on the phylum,
family, genus, and species level in the case of C-seal samples again
highlight the apparent irrelevance of the microbiota composition in
regard to the occurrence of AL. Only the presence or absence of a few
low-abundant opportunistic pathogenic groups was found to be
almost exclusively (weakly) associated with AL in C-seal samples.
These included the Tenericutes phylum (11/15 vs 19/45, P ¼ 0.037,
chi-square test), the Leptotrichia family (8/15 vs 9/45, P ¼ 0.013),
and Prevotella oralis (7/15 vs 6/45, P¼0 .007). The abundance of
Bacteroides uniformis and Bacteroides ovatus were found to be
negatively associated with the occurrence of AL in C-seal patients
(0.8% vs 2.5%, P ¼ 0.001 and 0.9% vs 0.4%, P ¼ 0.01). Of the
different Bacteroides species, B. uniformis was also the most nega-
tively correlated with P. oralis (P ¼ 0.008).
Differences between AL and non-AL in the non-C-seal
group were much more abundant. The Lachnospiraceae family
is associated with AL (40% vs 27%, P ¼ 0.010), and consists of
multiple important genera of which the Blautia genus (8% vs 4%,
P ¼ 0.003), in particular Blautia obeum, is the most strongly
associated with AL (7% vs 3%, P ¼ 0.005). The Bacteroidaceae
family is furthermore associated with AL (28% vs 17%,P¼ 0.008).
On the contrary, Prevotella copri and the Streptococcus genus are
both negatively associated with AL development in non-C-seal
patients (Tables 2 and 3). P. copri was completely absent in 8/10 of
the AL cases, whereas it was absent in only 11/48 of the non-AL
cases (P ¼ 0.0005, chi-square test).
Predictive Analyses
As Figure 1 and Supplemental Figure 1, http://links.lww.com/
SLA/B359 show, AL cases of non-C-seal patients seem to be almost
without exception dominated by Lachnospiraceae and Bacteroida-
ceae with correspondingly low microbial diversity scores. As a
measure for future predictive analyses, we defined a set of criteria
to describe a microbial composition that predisposes patients to
developing AL after surgery. These criteria were chosen as such
www.annalsofsurgery.com | 913
FIGURE 2. Microbial composition profile
of non-C-seal patients. AL cases are
depicted to the right of the dashed verti-
cal line and controls are on its left. The
dashed horizontal black lines represent
themedian simpson index value (%/100)
of controls (left) and AL cases (right) and
show that the diversity is higher in con-
trols (P ¼ 0.002). The orange lines repre-
sent themedian values of the sums (%) of
the 2 most dominant bacterial families,
Bacteroidaceae and Lachnospiraceae, and
show that this sum is on average lower in
controls than in AL cases [P ¼ 0.008 and
0.010 separately, respectively, for both
families and P ¼ 0.0002 when both fami-
lies are combined (orange lines)].
van Praagh et al Annals of Surgery  Volume 269, Number 5, May 2019that an approximately equal number of patients from the C-seal and
the non-C-seal patient cohort would meet these criteria. Samples
were prone to developing AL if the total sum of Lachnospiraceae and
Bacteroidaceae in them was higher than 60% and when the Simpson
diversity score on the family level was <0.75. Eight out of 14
samples from the non-C-seal group who met these criteria developed
AL. For the C-seal group, this was only 3 out of 13. The odds ratio for
developing AL when meeting the criteria as defined above was 0.9
for the C-seal group (P ¼ 0.9), but for the non-C-seal group this was
28 (P ¼ 0.00001).
DISCUSSION
This study shows a relation between the composition of the
intestinal microbiota and the subsequent development of AL after
stapled colorectal anastomoses, but only in patients who underwent
surgery without the additional C-seal that covered the anastomoses.
In a previous pilot study on AL, we analyzed 16 non-C-seal patients
13of whom 8 developed AL. The present study included an additional
TABLE 2. Main Associations With AL in Non-C-seal Samples
(MW-U Test)
Reduced Risk Average, % P
Prevotella copri 1.0 0.007
Streptococcus genus 2.6 0.012
Streptococcus salivarius 0.5 0.018
Eubacterium biforme 1.5 0.010
Increased risk
Lachnospiraceae 29 0.010
Blautia genus 4.9 0.004
Blautia obeum 3.8 0.005
Blautia glucerasei 0.7 0.014





Bacteroides fragilis 3.2 0.013
914 | www.annalsofsurgery.com63 C-seal and 44 non-C-seal patients, with 2 additional leakages in
the non-C-seal group.
Non-C-seal
In this larger group of non-C-seal samples, the correlations
with AL confirm most of the results we found in the pilot study, as a
high abundance of Lachnospiraceae and Bacteroidaceae and a lower
microbial diversity are still strongly associated with AL. A bacterial
composition that consists of 60% or more of these 2 families seems
predictive for AL.
The trophic network of species in intestinalmicrobiotawith a
low diversity may be more easily disturbed than in microbiota with
a high diversity.20 This disturbance could be provoked by preoper-
ative or surgical processes, such as intravenous antibiotics,
mechanical bowel preparation, the creation of deviating ostomies,
opioids, or even the impact of the surgery itself.20–23 A disturbed
microbial composition may affect the metabolic balance; a reduc-
tion of butyrate production might, for instance, initiate energy
deprivation, causing impaired functioning of the colonic cells and
their ability to heal. It has been found in rats that an intraluminal
infusion of SCFAs resulted in significantly stronger colonic anas-
tomoses.24 Rectal irrigation with SCFAs in humans with ulcerative
colitis or diversion colitis has also shown promise.9,25 Furthermore,
a disturbed microbiota of low diversity may lack colonization
resistance to pathogenic bacteria that could play a role in the
development of AL, for example, Enterococcus faecalis.26–28 It
would be very interesting to compare the microbiota at the time of
surgery with the microbiota at the time of AL.
In this study, the focus in the non-C-seal samples seems to be
on the importance of microbial diversity and possibly on the role of
mucin degradation, possibly with an important mediating role of the
Ruminococcaceae family, which contains a high number of impor-
tant butyrate-producing species such as F. prausnitzii. Of the 3 most
dominant microbial families in the gut, Bacteroidaceae (19%),
Lachnospiraceae (29%), and Ruminococcaceae (16%), the first 2
are strongly negatively correlated with microbial diversity. Both
Bacteroides and Blautia (from the Lachnospiraceae family) are
known mucin-degraders that mainly either produce acetate and
propionate or propionate and propanol, but neither of them produces
29,30butyrate. Despite their high prevalence, Ruminococcaceae are
 2017 The Author(s). Published by Wolters Kluwer Health, Inc.
TABLE 3. Defined Characteristics Included Samples
C-seal (n ¼ 63) Non-C-seal (n ¼ 59)
Control (n ¼ 47) AL (n ¼ 15) Control (n ¼ 49) AL (n ¼ 10)
Sex (male/female) 24/23 10/5 37/12 8/2
Age, y (SD) 63.3 (10.3) 66.8 (12.0) 53.3 (10.7) 62.2 (8.9)
Body mass index (SD), kg/m2 27.8 (5.3) 27.4 (3.0) 26.5 (3.7) 29.5 (5.7)
Average amount of comorbidities 1.8 2.3 1.6 2.6
Indication for surgery
Colorectal cancer 45 15 45 10
Diverticular disease 1 0 3 0
Other 1 0 1 0
Preoperative treatment
Radiotherapy
No radiotherapy 20 5 21 5
Short course 12 7 16 3
Long course 15 3 12 2
Chemotherapy 15 3 15 2
Corticosteroid use 0 0 3 1
Deviating ostomy present 4 0 7 1
ASA-score
1 8 2 11 2
2 32 11 31 5
3 4 2 7 2
Annals of Surgery  Volume 269, Number 5, May 2019 Colorectal Leakage and Microbiotastrongly positively associated with microbial diversity, especially the
metabolically highly important keystone species F. prausnitzii (7%)
and Ruminococcus bromii (3%).31
C-seal
In the C-seal trial, we found a trend to more AL in C-seal
patients than in non-C-seal patients.32 However, the overall microbial
composition in C-seal patients does not seem to play a role in the
occurrence of AL at first. Our observations suggest that the C-seal
influences the microbial composition after introduction. This may be
due to the barrier it creates between themucosa and the (fresh) luminal
content, interrupting the supply of new resources. The subsequent
reduced rate of metabolism (SCFA production), possibly reduces the
rate of mucin synthesis by the human host, negatively affects wound
healing.33 The C-seal may create a new ecosystem that benefits the
growthof potential opportunistic pathogens as seen inour analysis, like
P. oralis, Fusobacteriacea, Leptotrichiaceae, bacteria from the phy-
lumTenericutes, andEnterococci as seenbyothers,20 represent (if at all
present) a very small minority, but could perhaps prosper and subse-
quently increase inflammation in this new situation.
Another ecological factor might be that shielding off the
mucosa, and the subsequent lack of metabolism, makes the envi-
ronment more aerobic. As the metabolism diminishes, oxygen
diffusing from the blood into the lumen is utilized less rapidly,34
making life hard for commensal oxygen sensitive species while
facilitating growth for opportunistic facultative pathogens, such as
Enteroccocus species, which are shown to excrete gelatinase GeIE
causing degradation of the anastomotic tissue.20
Strengths and Limitations
Most of the information that is available on the composition of
the gut microbiota is derived from fecal samples. This reflects the
composition present in the lumen of the distal colon and rectum, but
is different from the composition in the mucosa.35 The bacterial DNA
from the mucus layer was isolated in this study, giving a much better
insight on the microbial composition around the anastomosis than a
fecal sample could provide. Although all patients had oral mechani-
cal bowel preparation and the intestine was checked on residual
 2017 The Author(s). Published by Wolters Kluwer Health, Inc.luminal content, we cannot guarantee that in some of the samples
small traces of luminal content might have been present.
The method used to identify the bacterial DNA has its
limitations because 16S rRNA sequencing can only detect relative
abundance and not the absolute density of bacterial DNA present in
the mucus. In addition, 16S analysis is only capable of identifying
particular species based upon their 16S rRNA gene; genetic variation
within species cannot be measured. Some species, like Escherichia
coli, have a huge genetic diversity, distinguishing pathogenic E. coli
from nonpathogenic E. coli is impossible with 16S analysis. Fur-
thermore, to confirm our hypotheses, our data should have included
themucosal microbiome of the patients after the surgery, and, ideally,
after the development of AL. As this is very difficult, alternatively,
fecal samples could be collected both before and after surgery, in
addition to the ‘‘donut’’ sample taken during surgery.
Regarding the prevention of AL, we would recommend future
research to be focused on altering the gut microbiota by diet before
surgery into another stable yet healthy low risk composition, favoring
Ruminococcaceae, P. copri, and a high microbial diversity.
CONCLUSIONS
The microbial composition in patients that underwent stan-
dard colorectal surgery has a predictive value in regard to whether
they develop AL or not. Patients seem to have a higher risk of
developing AL when their microbial diversity is low, which in turn is
often associated with an overabundance of members from the mucin-
degrading families Lachnospiraceae and Bacteroidaceae. The intro-
duction of a C-seal, however, completely negates the protective or
harmful consequences of the dominant gut microbiota before surgery
in regard to wound healing. Further studies should be conducted to
elicit the possible mechanisms between the microbial composition
and the development of AL.
ACKNOWLEDGMENTS
The authors thank Carien Bus-Spoor and Rudi Tonk for their
excellent work on processing samples and bioinformatics support,
and also thank the entire C-seal team for their help collecting all the
metadata and tissue samples.
www.annalsofsurgery.com | 915
van Praagh et al Annals of Surgery  Volume 269, Number 5, May 2019REFERENCES
1. Buchs NC, Gervaz P, Secic M, et al. Incidence, consequences, and risk factors
for anastomotic dehiscence after colorectal surgery: a prospective monocen-
tric study. Int J Colorectal Dis. 2008;23:265–270.
2. Hammond J, Lim S, Wan Y, et al. The burden of gastrointestinal anastomotic
leaks: an evaluation of clinical and economic outcomes. J Gastrointest Surg.
2014;18:1176–1185.
3. Chambers WM, Mortensen NJM. Postoperative leakage and abscess forma-
tion after colorectal surgery. Best Pract Res Clin Gastroenterol. 2004;18:
865–880.
4. Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a
new clinical frontier. Gut. 2016;65:330–339.
5. Hold GL, Smith M, Grange C, et al. Role of the gut microbiota in inflamma-
tory bowel disease pathogenesis: what have we learnt in the past 10 years?
World J Gastroenterol. 2014;20:1192–1210.
6. Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk for colorectal
cancer. J Natl Cancer Inst. 2013;105:1907–1911.
7. Hague A, Butt AJ, Paraskeva C. The role of butyrate in human colonic
epithelial cells: an energy source or inducer of differentiation and apoptosis?
Proc Nutr Soc. 1996;55:937–943.
8. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-
inflammatory commensal bacterium identified by gut microbiota analysis of
Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731–16736.
9. Harig JM, Soergel KH, Komorowski RA, et al. Treatment of diversion colitis
with short-chain-fatty acid irrigation. N Engl J Med. 1989;320:23–28.
10. Roediger WE. The starved colo—diminished mucosal nutrition, diminished
absorption, and colitis. Dis Colon Rectum. 1990;33:858–862.
11. Scales BS, Huffnagle GB. The microbiome in wound repair and tissue fibrosis.
J Pathol. 2013;229:323–331.
12. Abis GSA, Stockmann HBAC, van Egmond M, et al. Selective decontamina-
tion of the digestive tract in gastrointestinal surgery: useful in infection
prevention? A systematic review. J Gastrointest Surg. 2013;17:2172–2178.
13. van Praagh JB, de Goffau MC, Bakker IS, et al. Intestinal microbiota and
anastomotic leakage of stapled colorectal anastomoses: a pilot study. Surg
Endosc. 2016;30:2259–2265.
14. Bakker IS, Morks AN, Hoedemaker HOTC, et al. The C-seal trial: colorectal
anastomosis protected by a biodegradable drain fixed to the anastomosis by a
circular stapler, a multi-center randomized controlled trial. BMC Surg.
2012;12:23.
15. de Goffau MC, Luopajarvi K, Knip M, et al. Fecal microbiota composition
differs between children with -cell autoimmunity and those without. Diabetes.
2013;62:1238–1244.
16. Bartram AK, Lynch MDJ, Stearns JC, et al. Generation of multimillion-
sequence 16S rRNA gene libraries from complex microbial communities
by assembling paired-end illumina reads. Appl Environ Microbiol.
2011;77:3846–3852.
17. Heida FH, van Zoonen AGJF, Hulscher JBF, et al. A necrotizing enterocolitis-
associated gut microbiota is present in the meconium: results of a prospective916 | www.annalsofsurgery.com18. Masella AP, Bartram AK, Truszkowski JM, et al. PANDAseq: paired-end
assembler for illumina sequences. BMC Bioinformatics. 2012;13:31.
19. Ludwig W, Strunk O, Westram R, et al. ARB: a software environment for
sequence data. Nucleic Acids Res. 2004;32:1363–1371.
20. Shogan BD, Smith DP, Christley S, et al. Intestinal anastomotic injury alters
spatially defined microbiome composition and function. Microbiome.
2014;2:35.
21. Ohigashi S, Sudo K, Kobayashi D, et al. Significant changes in the intestinal
environment after surgery in patients with colorectal cancer. J Gastrointest
Surg. 2013;17:1657–1664.
22. Zaura E, Brandt BW, Teixeira de Mattos MJ, et al. Same exposure but two
radically different responses to antibiotics: resilience of the salivarymicrobiome
versus long-term microbial shifts in feces. MBio. 2015;6:e01693–e1715.
23. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine
colonic microbiome and adiposity. Nature. 2012;488:621–626.
24. Rolandelli RH, Koruda MJ, Settle RG, et al. Effects of intraluminal infusion of
short-chain fatty acids on the healing of colonic anastomosis in the rat.
Surgery. 1986;100:198–204.
25. Breuer RI, Buto SK, Christ ML, et al. Rectal irrigation with short-chain fatty
acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci.
1991;36:185–187.
26. Shogan BD, Belogortseva N, Luong PM, et al. Collagen degradation and
MMP9 activation by Enterococcus faecalis contribute to intestinal anasto-
motic leak. Sci Transl Med. 2015;7:286ra68.
27. Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against
intestinal pathogens. Nat Rev Immunol. 2013;13:790–801.
28. Lawley TD, Walker AW. Intestinal colonization resistance. Immunology.
2013;138:1–11.
29. Ouwerkerk JP, de Vos WM, Belzer C. Glycobiome: bacteria and mucus at the
epithelial interface. Best Pract Res Clin Gastroenterol. 2013;27:25–38.
30. Salyers AA, Vercellotti JR, West SE, et al. Fermentation of mucin and plant
polysaccharides by strains of Bacteroides from the human colon. Appl Environ
Microbiol. 1977;33:319–322.
31. Ze X, Duncan SH, Louis P, et al. Ruminococcus bromii is a keystone species
for the degradation of resistant starch in the human colon. ISME J.
2012;6:1535–1543.
32. Bakker IS, Morks AN, Cate Hoedemaker Ten HO, et al. Randomized clinical
trial of biodegradeable intraluminal sheath to prevent anastomotic leak after
stapled colorectal anastomosis. Br J Surg. 2017;10:587.
33. Ferreira TM, Leonel AJ, Melo MA, et al. Oral supplementation of butyrate
reduces mucositis and intestinal permeability associated with 5-Fluorouracil
administration. Lipids. 2012;47:669–678.
34. Khan MT, Duncan SH, Stams AJM, et al. The gut anaerobe Faecalibacterium
prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic
interphases. ISME J. 2012;6:1578–1585.
35. Zoetendal EG, Wright von A, Vilpponen-Salmela T, et al. Mucosa-associated
bacteria in the human gastrointestinal tract are uniformly distributed along the
colon and differ from the community recovered from feces. Appl Environ
Microbiol. 2002;68:3401–3407.study. Clin Infect Dis. 2016;62:863–870. 2017 The Author(s). Published by Wolters Kluwer Health, Inc.
